Skip to Content

Hemato, Volume 7, Issue 1

2026 March - 8 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (8)

  • Case Report
  • Open Access
2,546 Views
7 Pages

2 March 2026

Angioimmunoblastic T-cell lymphoma (AITL) is a rare subtype of peripheral T-cell lymphoma (PTCL) and is frequently associated with autoimmune phenomena. Clinically, AITL shows an aggressive disease course and poor prognosis with currently available t...

  • Article
  • Open Access
1,995 Views
8 Pages

Understanding Caregiver Knowledge to Improve Home-Based Management of Sickle Cell Disease in Zaria, Nigeria

  • Musilimat H. Faleye,
  • Hadiza Lawal,
  • Olukemi Ajamufua,
  • Niyi M. Adebiyi and ,
  • Jamilu A. Faruk,
  • Zainab M. Hassan and
  • Hafsat R. Ahmad
  • + 2 authors+ 0 author

28 February 2026

Background: Sickle cell disease (SCD) is a hereditary blood disorder marked by the production of abnormally shaped, rigid red blood cells that obstruct blood flow, resulting in pain, organ damage, and increased infection risk. SCD poses a significant...

(This article belongs to the Special Issue Hematopathology: Rare Hematological Diseases)
  • Article
  • Open Access
1 Citations
2,698 Views
14 Pages

26 February 2026

Objective: This study aimed to investigate erythrocyte morphological alterations in hematological malignancies, with particular emphasis on structural differences among leukemia subtypes and anemia. Materials and Methods: Peripheral blood samples wer...

(This article belongs to the Section Leukemias)
  • Case Report
  • Open Access
1 Citations
1,876 Views
9 Pages

Primary Small Bowel MALT Lymphoma with Concurrent Pulmonary Dissemination: A Case Report

  • María José Robledo Rivera,
  • Adriana Margarita Trejos Tenorio,
  • José Ortega Ramírez,
  • Gustavo Ariel Fridenberg and
  • Manuel Sureda González

11 February 2026

Marginal zone lymphomas (MZLs) are indolent mature B-cell neoplasms. Approximately 3.4% of gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas involve the small bowel. Pseudoaneurysmal dilation has been reported in up to 35% of patien...

(This article belongs to the Section Lymphomas)
  • Review
  • Open Access
1 Citations
3,994 Views
10 Pages

Alloimmunization in Pregnancy: A Practical Guide for Transfusion Medicine

  • Palma Manduzio,
  • Luigi Ciccone,
  • Valeria Cosima Elisena Cardo,
  • Antonietta Faleo and ,
  • Antonietta Ferrara,
  • Lucia Simone,
  • Libera Padovano and
  • Tommaso Granato
  • + 3 authors+ 0 author

13 January 2026

Background: Feto-maternal hemorrhages (FMHs) due to placenta disruption and bleeding from fetal maternal circulation can lead to life-threatening fetal anemia. These hemorrhages are more often of small volume and remain unreported. Sensitization to f...

(This article belongs to the Section Non Neoplastic Blood Disorders)
  • Article
  • Open Access
1,987 Views
12 Pages

Serum Oxidized LDL and Interleukin-10 as Biomarkers for Peripheral Artery Disease in Chronic Myeloid Leukemia Patients Receiving Tyrosine Kinase Inhibitor Therapy

  • Hernycane Sosilya,
  • Muhammad Noor Diansyah,
  • Merlyna Savitri,
  • Putu Niken Ayu Amrita and ,
  • Pradana Zaky Romadhon,
  • Hermina Novida,
  • Nadya Luthfah,
  • Ami Ashariati and
  • Siprianus Ugroseno Yudho Bintoro
  • + 4 authors+ 0 author

4 January 2026

Background/Objectives: Tyrosine kinase inhibitors (TKIs) have transformed the treatment of chronic myeloid leukemia (CML), yet emerging evidence indicates an increased risk of vascular adverse events, particularly peripheral artery disease (PAD). Rel...

  • Article
  • Open Access
1 Citations
2,726 Views
12 Pages

High-Initial-Dose Accelerated Titration Regimen of Ropeginterferon alfa-2b in Younger Patients with Polycythemia Vera and Essential Thrombocythemia: A Consecutive Case Series Study

  • Sung-Nan Pei,
  • Caleb Gon-Shen Chen,
  • Hsiao-Wen Kao,
  • Huey-En Tzeng and ,
  • Ming-Lih Huang,
  • Chih-Cheng Chen,
  • Jasmine Hsiang-Wei Wang,
  • Lennex Hsueh-Lin Yu and
  • Hsin-An Hou
  • + 4 authors+ 0 author

31 December 2025

Introduction: Ropeginterferon alfa-2b is an emerging treatment for polycythemia vera, with growing interest in its application for essential thrombocythemia and early myelofibrosis due to its extended dosing intervals and favorable tolerability profi...

(This article belongs to the Special Issue Hematopathology: Rare Hematological Diseases)
  • Case Report
  • Open Access
2,138 Views
9 Pages

Therapy-Related Myeloid Neoplasms After CAR-T Therapy: A Case Series with Distinct Cytogenetic Features and Comparison with Autologous Stem Cell Transplantation

  • Pilar Palomo-Moraleda,
  • Sara Alonso-Álvarez,
  • Lucía Morais-Bras,
  • Christian Sordo-Bahamonde and ,
  • Rocío Granda-Díaz,
  • Joud Zanabili-Al-Sibai,
  • Sofía García-Ferreiro,
  • Marco Moro-García,
  • Estefanía Pérez-López and
  • Ana P. González-Rodríguez
  • + 12 authors+ 7 authors

25 December 2025

Background: The emergence of therapy-related myelodysplastic syndrome (t-MN) after autologous stem cell transplantation (ASCT) is well documented. However, with the growing use of chimeric antigen receptor (CAR) T-cell therapy for relapsed/refractory...

XFacebookLinkedIn
Hemato - ISSN 2673-6357